Polymorphic forms of 1-4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride | Patent Number 08193195

US 08193195 B2
Application Number12945272
Publication NumberUS 20110190317 A1
Pendency1 year, 6 months, 26 days
Filled DateNov 12, 2010
Priority DateJun 5, 2002
Publication DateAug 4, 2011
Expiration DateJun 5, 2022
Inventor/ApplicantsHeike Kniel
Andreas Bathe
Susanne Rudolph
Bernd Helfert
Matthias Bartels
Steffen Neuenfeld
Henning Böttcher
ExaminesBARKER, MICHAEL P
Art Unit1626
Technology Center1600
Assignments
Merck Patentgesellschaft
Current
Merck PatentgesellschaftMerck & Co. Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.